Michael A. Pisetsky serves as Chief Business & Legal Affairs Officer at SI-BONE, Inc., a medical technology company pioneering minimally invasive solutions for sacroliliac joint dysfunction. In this role, he leads the company's legal, intellectual property, business development, and compliance functions, playing a pivotal role in strategic partnerships, mergers and acquisitions, and global expansion efforts. Pisetsky joined SI-BONE in 2018 as General Counsel and was promoted to his current position in 2021, bringing his extensive expertise to support the company's growth from a innovative startup to a publicly traded leader in musculoskeletal health. With over 25 years of experience in the medical device and life sciences industries, Pisetsky previously held senior legal positions at Intuitive Surgical, where he served as Vice President and Associate General Counsel from 2013 to 2018, overseeing complex litigation, regulatory matters, and international operations. Prior to that, he was Vice President and Deputy General Counsel at Boston Scientific Corporation from 2006 to 2013, managing global legal teams and key transactions. His career also includes roles at Genzyme Corporation and earlier positions at leading law firms such as Goodwin Procter and Hale and Dorr. Pisetsky's achievements include guiding multiple high-profile acquisitions and licensing deals, strengthening IP portfolios, and ensuring compliance amid rapid industry evolution. A Harvard Law School graduate (J.D., 1994) and summa cum laude alumnus of Brandeis University (B.A., 1991), he is recognized for his strategic acumen and contributions to advancing innovative therapies, earning accolades such as being named to the 2023 Law360 Life Sciences MVP list.